Irish pharma group ICON plc carried out trial of Pfizer-BioNTech vaccine
The Irish Times
The trial, involving 44,000 participants, was largest trial of a Covid-19 vaccine
Irish clinical trials group Icon has revealed that it carried out the late-stage trial of the Pfizer-BioNTech coronavirus vaccine.
The trial, which involved 44,000 participants over a four-month period last year, was the largest trial of a Covid-19 vaccine.
Pfizer and BioNTech were the first to announce positive efficacy results from a late-stage study, and the first to receive authorisation for deployment.
